Best GLP-1 Weight Loss Programs in Connecticut (2026)

Most programs require a BMI of 30 or higher, or a BMI of 27+ with at least one weight-related health condition such as type 2 diabetes, high blood pressure, or high cholesterol. You must be 18 or older. A licensed provider will evaluate your medical history during your telehealth consultation to determine eligibility.

Yes, several telehealth providers prescribe tirzepatide (the active ingredient in Mounjaro and Zepbound) to Connecticut residents. Availability varies by provider — some offer only compounded tirzepatide, others prescribe brand-name versions, and a few do not carry tirzepatide at all. Check individual program details above for specific medication offerings.

Brand-name GLP-1s like Ozempic, Wegovy, and Zepbound are FDA-approved and manufactured by pharmaceutical companies. Compounded versions contain the same active ingredient but are prepared by compounding pharmacies, often at lower cost. The FDA permits compounding when brand-name drugs face shortages. Both types require a prescription from a licensed provider.

No. Most telehealth GLP-1 programs listed here operate on a cash-pay model and do not require insurance. Some providers offer insurance billing for brand-name medications like Wegovy or Zepbound, which can reduce costs if your plan covers them. Compounded and telehealth-direct programs typically bypass insurance entirely.

Pricing varies based on medication type and program structure. Some providers offer compounded semaglutide starting around $149/month, while brand-name medications and programs with additional coaching or monitoring typically cost more. The lowest advertised starting price among major telehealth providers is approximately $129/month, though total costs depend on your specific treatment plan and dosage.